Eli Lilly Covid Antibody Drug Gets Emergency FDA Clearance

Nov.09 — Pfizer Inc. and BioNTech SE are reporting positive results from their covid-19 vaccine trials, signaling a major breakthrough in the fight to contain the worst outbreak in a century. Meanwhile, Eli Lilly & Co.'s covid-19 antibody therapy has just been granted emergency FDA clearance. Bloomberg’s Michelle Cortez reports on “Bloomberg Daybreak: Asia.”

Watch the video at Bloomberg – Corona Outbreak

Related Articles

Back to top button